2026 Annual Meeting | Industry Therapeutic Update from Eli Lilly: Kisunla (donanemab-azbt): Expert Discussions for Clinical Approaches

Date Tuesday 04/21/26

Time 11:45 AM - 12:45 PM CDT Add To Calendar

Session Format This program will be presented in-person only

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Industry Therapeutic Update

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Join us for an educational session where we will discuss how to identify appropriate patients, and the efficacy and safety profile from our latest clinical trials. Please see the Important Safety Information, including Boxed Warning, the Full Prescribing Information, and Medication Guide provided at the Product Theater and at https://kisunla.lilly.com/hcp This program is sponsored by, and the speaker is presenting on behalf of, Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit.

CME Available No CME available

Event Timeline
11:45 AM - 12:45 PM CDT	Speaker	Eli Lilly

Faculty Disclosures
Ronald L. Schwartz, MD	No disclosure on file

��ɫ��

��ɫ��